---
title: "Tong Ren Tang Technologies Sets AGM to Approve Dividend and Share Issuance Mandate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284189062.md"
description: "Tong Ren Tang Technologies Co. has scheduled its 2025 annual general meeting for June 12, 2026, in Beijing. Shareholders will review the audited financial statements and vote on a proposed final dividend of RMB0.18 per share. The company also seeks approval to reappoint Ernst & Young as auditors and a general mandate to issue up to 20% additional shares to enhance capital flexibility. Tong Ren Tang specializes in traditional Chinese medicine and is listed in Hong Kong, with a current market cap of HK$5.02B."
datetime: "2026-04-27T09:45:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284189062.md)
  - [en](https://longbridge.com/en/news/284189062.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284189062.md)
---

# Tong Ren Tang Technologies Sets AGM to Approve Dividend and Share Issuance Mandate

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Tong Ren Tang Technologies Co ( (HK:1666) ) just unveiled an announcement.

Tong Ren Tang Technologies has convened its 2025 annual general meeting for 12 June 2026 in Beijing, where shareholders will review the audited 2025 financial statements and the board’s annual report. The company will also seek approval for a final dividend of RMB0.18 per share, signalling confidence in its earnings and providing a cash return to investors.

Shareholders will vote on reappointing Ernst & Young and Ernst & Young Hua Ming LLP as overseas and domestic auditors for 2026, as well as amendments to meeting rules and the articles of association. The board is further asking for a general mandate to issue up to 20% additional shares, which would give management flexibility to raise capital and adjust the company’s capital structure as needed.

**More about Tong Ren Tang Technologies Co**

Tong Ren Tang Technologies Co. Ltd. is a Mainland China-based pharmaceutical company specialising in traditional Chinese medicine products. Listed in Hong Kong, it focuses on manufacturing and distributing herbal remedies and health supplements, serving both domestic and international markets through retail and wholesale channels.

**YTD Price Performance:** -11.11%

**Average Trading Volume:** 1,000,911

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$5.02B

See more data about 1666 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [03613.HK](https://longbridge.com/en/quote/03613.HK.md)
- [01666.HK](https://longbridge.com/en/quote/01666.HK.md)
- [600085.CN](https://longbridge.com/en/quote/600085.CN.md)

## Related News & Research

- [Tong Ren Tang Subsidiary Posts Lower 2025 Profit as Revenue and Margins Decline](https://longbridge.com/en/news/279954067.md)
- [The Trading Awards: Voting is open until 19 May](https://longbridge.com/en/news/286793607.md)
- [Stocks in Play: Interfor Corporation](https://longbridge.com/en/news/286585579.md)
- [ARTRARI ONE CAPITAL CORP. REPORTS ON VOTING RESULTS FROM THE 2026 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS](https://longbridge.com/en/news/286606232.md)
- [Wide postpones 2026 annual meeting to June 17; proxy voting deadline June 16](https://longbridge.com/en/news/286911986.md)